Navigation Links
RNase AWAY(r) from Sigma-Aldrich

ProductsRNase AWAY(r) from Sigma-Aldrich
Company Sigma-Aldrich
Item RNase AWAY(r)
Description Special grade: for molecular biology
Density: 1.000 g/mL (20 C)
Info Sigma-AldrichSigma-Aldrich
Sigma-Aldrich Corp.
St. Louis, MO, USA
Customer Service: 800-325-3010
Tech Support: 800-325-5832
Fax Number: 314-771-5757
Web Site:
NOTE: Price information is approximate list price and actual prices may vary.

Related biology products :

1. DNase I (RNase-free) (2 U/l) from Ambion
2. QIAGEN RNase Inhibitor (7500 U) from QIAGEN
3. ShortCut RNase III from New England Biolabs
4. RNase H from Roche Applied Science
5. RNase-Free Dnase from BD Biosciences Pharmingen
6. RQ1 RNase-Free DNase from Promega
7. DNase I, RNase-free; special quality for molecular biology from Roche Applied Science
8. SuperScript II RNase H- Reverse Transcriptase from Invitrogen
9. SuperScript II RNase H- Reverse Transcriptase from Invitrogen
10. RNase Inhibitor from Applied Biosystems
11. RNaseOUT Recombinant Ribonuclease Inhibitor from Invitrogen
(Date:10/29/2015)... Oct. 29, 2015  The J. Craig Venter Institute ... "DNA Synthesis and Biosecurity: Lessons Learned and Options for ... Health and Human Services guidance for synthetic biology providers ... --> --> Synthetic ... the potential to pose unique biosecurity threats. It now ...
(Date:10/29/2015)... health pioneer, Joseph C. Kvedar , MD, describes ... wellness, and the business opportunities that arise from it ... Healthy Things . Long before health and wellness ... vice president, Connected Health, Partners HealthCare, was creating a ... the hospital or doctor,s office into the day-to-day lives ...
(Date:10/27/2015)... -- In the present market scenario, security is one ... verticals such as banking, healthcare, defense, electronic gadgets, and ... secure & simplified access control and growing rate of ... bank accounts, misuse of users, , and so on. ... and smartphones are expected to provide potential opportunities for ...
Breaking Biology News(10 mins):
(Date:11/25/2015)... , Nov. 25, 2015 /PRNewswire/ - Aeterna Zentaris Inc. ... its business and prospects remain fundamentally strong and ... (zoptarelin doxorubicin) recently received DSMB recommendation to continue ... following review of the final interim efficacy and ... Primary Endpoint in men with heavily pretreated castration- ...
(Date:11/25/2015)... ... November 25, 2015 , ... Jessica Richman and Zachary Apte, ... their initial angel funding process. Now, they are paying it forward to other ... stage investments in the microbiome space. In this, they join other successful ...
(Date:11/24/2015)... SAN DIEGO , Nov. 24, 2015 Halozyme Therapeutics, ... Jaffray Healthcare Conference in New York on ... Dr. Helen Torley , president and CEO, will provide a ... New York at 1:00 p.m. ET/10:00 a.m. ... communication and investor relations, will provide a corporate overview. --> ...
(Date:11/24/2015)... 24, 2015 /PRNewswire/ - Aeterna Zentaris Inc. (NASDAQ:  AEZS) (TSX: ... behalf of the Toronto Stock Exchange, confirms that as ... no corporate developments that would cause the recent movements ... --> About Aeterna Zentaris Inc. ... --> Aeterna Zentaris is a specialty biopharmaceutical company ...
Breaking Biology Technology: